4.7 Article

Antitumor Agents 268. Design, Synthesis, and Mechanistic Studies of New 9-Substituted Phenanthrene-Based Tylophorine Analogues as Potent Cytotoxic Agents

期刊

JOURNAL OF MEDICINAL CHEMISTRY
卷 52, 期 16, 页码 5262-5268

出版社

AMER CHEMICAL SOC
DOI: 10.1021/jm9009263

关键词

-

资金

  1. National Cancer Institute [CA 17625]
  2. National Research Program for Genomic Medicine [DOH98-TD-G-111-007]

向作者/读者索取更多资源

Nineteen new phenanthrene-based tylophorine analogues with various functional groups on the piperidine moiety were designed, synthesized, and evaluated for in vitro anticancer activity against four human tumor cell lines. Analogues 15 and 21 showed approximately 2-fold enhanced inhibitory activity as compared with our prior lead compound (PBT-1), Analogues 23 and 24 with S- and R-configured substituents, respectively, at the piperidine 3'-position exhibited comparable cytotoxicity to that of PBT-1. Furthermore, mechanistic studies to investigate the effects of the new compounds oil Akt protein in lung cancer cells and the NF-kappa B signaling pathway suggested that the compounds may exert their inhibitory activity oil tumor cells through inhibition of activation of both Akt and NF-kB signaling pathway.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, Research & Experimental

A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant

Yi-Chung Chang, Chi-Fan Yang, Yi-Fen Chen, Chia-Chun Yang, Yuan-Lin Chou, Hung-Wen Chou, Tein-Yao Chang, Tai-Ling Chao, Shu-Chen Hsu, Si-Man Ieong, Ya-Min Tsai, Ping-Cheng Liu, Yuan-Fan Chin, Jun-Tung Fang, Han-Chieh Kao, Hsuan-Ying Lu, Jia-Yu Chang, Ren-Shiuan Weng, Qian-Wen Tu, Fang-Yu Chang, Kuo-Yen Huang, Tong-Young Lee, Sui-Yuan Chang, Pan-Chyr Yang

Summary: The inhalable siRNA drug C6G25S, covering 99.8% of SARS-CoV-2 variants, shows effectiveness in inhibiting dominant strains and preventing lung damage in animal models.

EMBO MOLECULAR MEDICINE (2022)

Editorial Material Medicine, Research & Experimental

Using host receptor as a decoy to treat COVID-19: a solution for immune escape?

Kuo-Yen Huang, Ming-Shiu Lin, Pan-Chyr Yang

Summary: There is an unmet clinical need to end the COVID-19 pandemic. The SARS-CoV-2 has continued to evolve, posing a challenge to vaccine efficacy and neutralizing antibody therapies. The Omicron variants are driving the fifth wave of the pandemic due to their ability to evade prior immunity and resist therapeutic antibodies. A recent study shows that engineered decoy ACE2 can reduce lung injury and improve survival in transgenic mice infected with a lethal dose of SARS-CoV-2, potentially targeting the Omicron variant.

EMBO MOLECULAR MEDICINE (2022)

Article Oncology

Stage Shift Improves Lung Cancer Survival: Real-World Evidence

Ching-Yao Yang, Yen -Ting Lin, Li-Ju Lin, Ya-Hsuan Chang, Hsuan-Yu Chen, Yi -Pin Wang, Jin -Yuan Shih, Chong-Jen Yu, Pan-Chyr Yang

Summary: Taiwan implemented several health policies including smoking cessation, precision therapy, and LDCT screening to combat lung cancer. The nationwide cancer registry data showed that although lung cancer incidence continued to rise, the mortality rate decreased over time. The analysis of patient data from National Taiwan University Hospital revealed a significant improvement in 5-year survival, particularly in late-stage lung cancer, suggesting the importance of early detection.

JOURNAL OF THORACIC ONCOLOGY (2023)

Article Oncology

Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit

Emily Pei-Ying Lin, Chih-Yuan Hsu, Jeng-Fong Chiou, Lynne Berry, Leora Horn, Paul Bunn, James Chih-Hsin Yang, Pan-Chyr Yang, Alex A. Adjei, Yu Shyr

Summary: This study utilizes meta-analysis to demonstrate that there is a roughly 10% increase in long-term survival probability among ICI long-term survivors in PD-L1 positive subpopulations across ICI treatment lines. Additionally, the ST-HR consistently performs worse than the Cox HR. Neither the LT-DP nor the ST-HR achieved statistical significance for patients with PD-L1 less than 1%. This analysis provides greater insight into the treatment effect of ICI in published trials.

JOURNAL OF THORACIC ONCOLOGY (2022)

Article Chemistry, Multidisciplinary

An acid degradable, lactate oxidizing nanoparticle formulation for non-small cell lung cancer virotherapy

S-Ja Tseng, Ivan M. Kempson, Zi-Xian Liao, Yi-Cheng Ho, Pan-Chyr Yang

Summary: Resistance to approved targeted therapies in non-small cell lung cancer (NSCLC) is a challenge, and oncolytic virotherapy has potential but faces systemic administration and viral delivery issues. This study designs an acid-degradable nanoparticle that releases virus using lactate secreted by tumors, offering a potential avenue for NSCLC treatment.

NANO TODAY (2022)

Article Biology

HLJ1 amplifies endotoxin-induced sepsis severity by promoting IL-12 heterodimerization in macrophages

Wei-Jia Luo, Sung-Liang Yu, Chia-Ching Chang, Min-Hui Chien, Ya-Ling Chang, Keng-Mao Liao, Pei-Chun Lin, Kuei-Pin Chung, Ya-Hui Chuang, Jeremy J. W. Chen, Pan-Chyr Yang, Kang-Yi Su

Summary: HLJ1 knockout mice show reduced organ injury and mortality in lipopolysaccharide-induced endotoxic shock. HLJ1 deletion affects IFN-gamma-related gene signatures in distinct immune cell clusters. HLJ1 deficiency leads to reduced IL-12 levels, dampened IFN-gamma production in natural killer cells, and improved survival rate. HLJ1 converts misfolded IL-12p35 homodimers to monomers, maintaining bioactive IL-12p70 heterodimerization and secretion.
Article Oncology

Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia

Tetsuya Mitsudomi, Daniel Tan, James Chih-Hsin Yang, Myung-Ju Ahn, Ullas Batra, Byoung-Chul Cho, Gerardo Cornelio, Tony Lim, Tony Mok, Kumar Prabhash, Thanyanan Reungwetwattana, Sheng-Xiang Ren, Navneet Singh, Shinichi Toyooka, Yi-Long Wu, Pan-Chyr Yang, Yasushi Yatabe

Summary: This study provides consensus recommendations for biomarker testing in Asian patients with non-small cell lung cancer. It highlights the importance of analyzing actionable genetic alterations in EGFR, ALK, ROS1, and others, including uncommon EGFR mutations. The role of liquid biopsy in assessing tumor biomarkers is also discussed.

JOURNAL OF THORACIC ONCOLOGY (2023)

Article Medicine, Research & Experimental

Senomorphic effect of diphenyleneiodonium through AMPK/MFF/DRP1 mediated mitochondrial fission

Keng-Mao Liao, Chih-Jung Chen, Wei-Jia Luo, Chen-Wei Hsu, Sung-Liang Yu, Pan-Chyr Yang, Kang-Yi Su

Summary: With an aging population and the numerous health impacts associated with old age, there is a growing need to find effective anti-aging drugs. In this study, diphenyleneiodonium (DPI) was identified as a potential anti-aging drug that promotes mitochondrial fission. DPI was found to reduce senescence-associated beta-galactosidase positive cells and increase proliferating cells. It also downregulated cell cycle arrest genes and SASP factors. DPI treatment in mice showed reduced senescence markers and improved physical impairments.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Article Medicine, Research & Experimental

PM2.5 promotes lung cancer progression through activation of the AhR-TMPRSS2-IL18 pathway

Tong-Hong Wang, Kuo-Yen Huang, Chin-Chuan Chen, Ya-Hsuan Chang, Hsuan-Yu Chen, Chuen Hsueh, Yi-Tsen Liu, Shuenn-Chen Yang, Pan-Chyr Yang, Chi-Yuan Chen

Summary: This study investigated the molecular mechanisms of PM2.5 exposure on lung cancer progression. Short-term exposure to PM2.5 activated the EGFR pathway in lung cancer cells, while long-term exposure persistently promoted EGFR activation, cell proliferation, anchorage-independent growth, and tumor growth in a xenograft mouse model. PM2.5 activated AhR to translocate into the nucleus and promoted EGFR activation. AhR further interacted with the promoter of TMPRSS2, thereby upregulating TMPRSS2 and IL18 expression to promote cancer progression. Depletion of TMPRSS2 suppressed anchorage-independent growth and xenograft tumor growth. TMPRSS2 expression correlated with nuclear AhR expression and cancer stage in lung cancer patient tissue.

EMBO MOLECULAR MEDICINE (2023)

Editorial Material Oncology

Never Say No to Never-Smokers

Chao-Hua Chiu, Pan-Chyr Yang

JOURNAL OF THORACIC ONCOLOGY (2023)

Article Multidisciplinary Sciences

Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population

Jianxin Shi, Kouya Shiraishi, Jiyeon Choi, Keitaro Matsuo, Tzu-Yu Chen, Juncheng Dai, Rayjean J. Hung, Kexin Chen, Xiao-Ou Shu, Young Tae Kim, Maria Teresa Landi, Dongxin Lin, Wei Zheng, Zhihua Yin, Baosen Zhou, Bao Song, Jiucun Wang, Wei Jie Seow, Lei Song, I-Shou Chang, Wei Hu, Li-Hsin Chien, Qiuyin Cai, Yun-Chul Hong, Hee Nam Kim, Yi-Long Wu, Maria Pik Wong, Brian Douglas Richardson, Karen M. Funderburk, Shilan Li, Tongwu Zhang, Charles Breeze, Zhaoming Wang, Batel Blechter, Bryan A. Bassig, Jin Hee Kim, Demetrius Albanes, Jason Y. Y. Wong, Min-Ho Shin, Lap Ping Chung, Yang Yang, She-Juan An, Hong Zheng, Yasushi Yatabe, Xu-Chao Zhang, Young-Chul Kim, Neil E. Caporaso, Jiang Chang, James Chung Man Ho, Michiaki Kubo, Yataro Daigo, Minsun Song, Yukihide Momozawa, Yoichiro Kamatani, Masashi Kobayashi, Kenichi Okubo, Takayuki Honda, Dean H. Hosgood, Hideo Kunitoh, Harsh Patel, Shun-ichi Watanabe, Yohei Miyagi, Haruhiko Nakayama, Shingo Matsumoto, Hidehito Horinouchi, Masahiro Tsuboi, Ryuji Hamamoto, Koichi Goto, Yuichiro Ohe, Atsushi Takahashi, Akiteru Goto, Yoshihiro Minamiya, Megumi Hara, Yuichiro Nishida, Kenji Takeuchi, Kenji Wakai, Koichi Matsuda, Yoshinori Murakami, Kimihiro Shimizu, Hiroyuki Suzuki, Motonobu Saito, Yoichi Ohtaki, Kazumi Tanaka, Tangchun Wu, Fusheng Wei, Hongji Dai, Mitchell J. Machiela, Jian Su, Yeul Hong Kim, In-Jae Oh, Victor Ho Fun Lee, Gee-Chen Chang, Ying-Huang Tsai, Kuan-Yu Chen, Ming-Shyan Huang, Wu-Chou Su, Yuh-Min Chen, Adeline Seow, Jae Yong Park, Sun-Seog Kweon, Kun-Chieh Chen, Yu-Tang Gao, Biyun Qian, Chen Wu, Daru Lu, Jianjun Liu, Ann G. Schwartz, Richard Houlston, Margaret R. Spitz, Ivan P. Gorlov, Xifeng Wu, Ping Yang, Stephen Lam, Adonina Tardon, Chu Chen, Stig E. Bojesen, Mattias Johansson, Angela Risch, Heike Bickeboeller, Bu-Tian Ji, H-Erich Wichmann, David C. Christiani, Gadi Rennert, Susanne Arnold, Paul Brennan, James McKay, John K. Field, Sanjay S. Shete, Loic Le Marchand, Geoffrey Liu, Angeline Andrew, Lambertus A. Kiemeney, Shan Zienolddiny-Narui, Kjell Grankvist, Mikael Johansson, Angela Cox, Fiona Taylor, Jian-Min Yuan, Philip Lazarus, Matthew B. Schabath, Melinda C. Aldrich, Hyo-Sung Jeon, Shih Sheng Jiang, Jae Sook Sung, Chung-Hsing Chen, Chin-Fu Hsiao, Yoo Jin Jung, Huan Guo, Zhibin Hu, Laurie Burdett, Meredith Yeager, Amy Hutchinson, Belynda Hicks, Jia Liu, Bin Zhu, Sonja I. Berndt, Wei Wu, Junwen Wang, Yuqing Li, Jin Eun Choi, Kyong Hwa Park, Sook Whan Sung, Li Liu, Chang Hyun Kang, Wen-Chang Wang, Jun Xu, Peng Guan, Wen Tan, Chong-Jen Yu, Gong Yang, Alan Dart Loon Sihoe, Ying Chen, Yi Young Choi, Jun Suk Kim, Ho-Il Yoon, In Kyu Park, Ping Xu, Qincheng He, Chih-Liang Wang, Hsiao-Han Hung, Roel C. H. Vermeulen, Iona Cheng, Junjie Wu, Wei-Yen Lim, Fang-Yu Tsai, John K. C. Chan, Jihua Li, Hongyan Chen, Hsien-Chih Lin, Li Jin, Jie Liu, Norie Sawada, Taiki Yamaji, Kathleen Wyatt, Shengchao A. Li, Hongxia Ma, Meng Zhu, Zhehai Wang, Sensen Cheng, Xuelian Li, Yangwu Ren, Ann Chao, Motoki Iwasaki, Junjie Zhu, Gening Jiang, Ke Fei, Guoping Wu, Chih-Yi Chen, Chien-Jen Chen, Pan-Chyr Yang, Jinming Yu, Victoria L. Stevens, Joseph F. Fraumeni, Nilanjan Chatterjee, Olga Y. Gorlova, Chao Agnes Hsiung, Christopher I. Amos, Hongbing Shen, Stephen J. Chanock, Nathaniel Rothman, Takashi Kohno, Qing Lan

Summary: This study identified 12 novel susceptibility variants for lung adenocarcinoma and a total of 28 loci associated with the disease in East Asian populations. Additionally, new candidate genes were discovered, contributing to the understanding of the disease etiology. These findings have important implications for the research and translational applications of lung adenocarcinoma in individuals from East Asian populations.

NATURE COMMUNICATIONS (2023)

Article Multidisciplinary Sciences

Small-molecule PIK-93 modulates the tumor microenvironment to improve immune checkpoint blockade response

Chia-Yi Lin, Kuo-Yen Huang, Shih-Han Kao, Ming-Shiu Lin, Chih-Chien Lin, Shuenn-Chen Yang, Wei-Chia Chung, Ya-Hsuan Chang, Rong-Jie Chein, Pan-Chyr Yang

Summary: In this study, a small molecule drug called PIK-93 was discovered to modulate the tumor microenvironment by reducing PD-L1 levels and enhancing the cytotoxicity of M1 macrophages. Combined with anti-PD-L1 antibodies, PIK-93 treatment enhanced T cell activation, inhibited tumor growth, and increased the recruitment of tumor-infiltrating lymphocytes.

SCIENCE ADVANCES (2023)

Article Biology

LCRMP-1 is required for spermatogenesis and stabilises spermatid F-actin organization via the PI3K-Akt pathway

Jung-Hsuan Chang, Chia-Hua Chou, Jui-Ching Wu, Keng-Mao Liao, Wei-Jia Luo, Wei-Lun Hsu, Xuan-Ren Chen, Sung-Liang Yu, Szu-Hua Pan, Pan-Chyr Yang, Kang-Yi Su

Summary: Mice deficient in LCRMP-1 show reduced fertility and perturbed F-actin cytoskeleton dynamics via the PI3K-Akt-mTOR axis. LCRMP-1 is abundantly expressed in the testis and plays a crucial role in spermatogenesis. LCRMP-1 deficiency causes disorganized F-actin due to unbalanced signaling of F-actin dynamics through upregulated PI3K-Akt-mTOR signaling, leading to aberrant spermiation and reduced fertility.

COMMUNICATIONS BIOLOGY (2023)

Article Oncology

Lung Cancer Screening in Asia: An Expert Consensus Report

David Chi-Leung Lam, Chong-Kin Liam, Sita Andarini, Samina Park, Daniel S. W. Tan, Navneet Singh, Seung Hun Jang, Varut Vardhanabhuti, Antonio B. Ramos, Tomio Nakayama, Nguyen Viet Nhung, Kazuto Ashizawa, Yeun-Chung Chang, Jamsak Tscheikuna, Cong Cung Van, Wai Yee Chan, Yeur-Hur Lai, Pan-Chyr Yang

Summary: The incidence and mortality of lung cancer are highest in Asia compared to Europe and USA. In some areas in Asia, there is limited availability of robust diagnostic tools and treatment modalities, making it necessary to have a more specific approach for screening and early detection of lung cancer.

JOURNAL OF THORACIC ONCOLOGY (2023)

暂无数据